Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Asperger syndrome: a proton magnetic resonance spectroscopy study of brain.

Murphy DG, Critchley HD, Schmitz N, McAlonan G, Van Amelsvoort T, Robertson D, Daly E, Rowe A, Russell A, Simmons A, Murphy KC, Howlin P.

Arch Gen Psychiatry. 2002 Oct;59(10):885-91.

PMID:
12365875
2.

Prefrontal and medial temporal correlates of repetitive violence to self and others.

Critchley HD, Simmons A, Daly EM, Russell A, van Amelsvoort T, Robertson DM, Glover A, Murphy DG.

Biol Psychiatry. 2000 May 15;47(10):928-34.

PMID:
10807966
3.

A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.

Jang JH, Kwon JS, Jang DP, Moon WJ, Lee JM, Ha TH, Chung EC, Kim IY, Kim SI.

Am J Psychiatry. 2006 Jul;163(7):1202-7.

PMID:
16816225
4.

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T.

Psychiatry Res. 1995 Nov 10;61(4):193-200.

PMID:
8748464
5.

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T.

Arch Neurol. 2001 May;58(5):729-35.

PMID:
11346367
6.

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

Reneman L, Majoie CB, Flick H, den Heeten GJ.

AJNR Am J Neuroradiol. 2002 Feb;23(2):231-7.

7.

Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.

Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.

Arch Gen Psychiatry. 2006 Sep;63(9):969-76.

PMID:
16952999
8.

Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-Tesla.

Kitamura H, Shioiri T, Kimura T, Ohkubo M, Nakada T, Someya T.

Acta Psychiatr Scand. 2006 Aug;114(2):101-8.

PMID:
16836597
9.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
10.

Developmental delay in children: assessment with proton MR spectroscopy.

Filippi CG, Uluğ AM, Deck MD, Zimmerman RD, Heier LA.

AJNR Am J Neuroradiol. 2002 May;23(5):882-8.

11.

Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging.

O'Brien FM, Page L, O'Gorman RL, Bolton P, Sharma A, Baird G, Daly E, Hallahan B, Conroy RM, Foy C, Curran S, Robertson D, Murphy KC, Murphy DG.

Psychiatry Res. 2010 Nov 30;184(2):77-85. doi: 10.1016/j.pscychresns.2010.08.007. Epub 2010 Oct 16.

PMID:
20952166
12.

Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy.

Lundbom N, Gaily E, Vuori K, Paetau R, Liukkonen E, Rajapakse JC, Valanne L, Häkkinen AM, Granström ML.

Epilepsia. 2001 Dec;42(12):1507-14.

13.

The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.

Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):120-5. Epub 2005 Oct 19.

PMID:
16236417
14.

Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.

Oner O, Devrimci-Ozguven H, Oktem F, Yagmurlu B, Baskak B, Munir KM.

AJNR Am J Neuroradiol. 2007 Sep;28(8):1494-8.

15.

Late proton MR spectroscopy in children after traumatic brain injury: correlation with cognitive outcomes.

Hunter JV, Thornton RJ, Wang ZJ, Levin HS, Roberson G, Brooks WM, Swank PR.

AJNR Am J Neuroradiol. 2005 Mar;26(3):482-8.

16.

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.

Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.

Schizophr Res. 2003 Nov 1;64(1):63-71.

PMID:
14511802
17.

Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.

Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH.

Arch Gen Psychiatry. 2005 Apr;62(4):444-52.

PMID:
15809412
18.

A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.

Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN.

Neurology. 1998 Oct;51(4):1104-9.

PMID:
9781537
19.

1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.

Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer D, Keshavan MS, Soares JC.

J Affect Disord. 2005 May;86(1):61-7.

PMID:
15820271
20.

Reduced prefrontal N-acetylaspartate in stroke patients with apathy.

Glodzik-Sobanska L, Slowik A, Kieltyka A, Kozub J, Sobiecka B, Urbanik A, Szczudlik A.

J Neurol Sci. 2005 Nov 15;238(1-2):19-24. Epub 2005 Aug 5.

PMID:
16084528
Items per page

Supplemental Content

Write to the Help Desk